• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Zambia trial cuts severe malaria deaths by 96 per cent

Shiloh

Editor, Senior Moderator
Source: https://www.scidev.net/sub-saharan-africa/health/news/zambia-trial-cuts-severe-malaria-deaths.html

28/08/18
Zambia trial cuts severe malaria deaths by 96 per cent

Zambia had about three million malaria cases in 2016
A pilot trial shows a drug can cut severe malaria deaths by 96 per cent
If achieved during large-scale implementation, the result could be ground-breaking

By: Baraka Rateng?

[KISUMU, KENYAI] A suppository form of the common antimalarial artesunate has dramatically cut child deaths from severe malaria in a trial in rural Zambia, one of the organisations behind the programme has said...

...During a 12-month trial with a suppository formulation of the common antimalarial artesunate, deaths from severe malaria cases declined from eight to 0.25 per cent despite identifying 225 and 1,215 cases respectively at the study?s baseline and endline, the researchers announced the findings today...
 
Back
Top Bottom